Investor Alert: Kaplan Fox Investigates Helius Medical Technologies, Inc. (press release):
“NEW YORK, Feb. 7, 2019 /PRNewswire/ — Kaplan Fox & Kilsheimer LLP has been investigating claims on behalf of investors of Helius Medical Technologiues, Inc. (“Helius” or the “Company”) (Nasdaq: HSDT).
On January 22, 2019, after the market opened, White Diamond Research published [Read more…] about Problems grow for neuromodulation firm Helius Medical Technologies